News

You are here

Jan 23, 2012

Iproteos, among the 31 new technological spin-off companies launched in 2011 with support from ACC1Ó, the agency set up by the Catalan Government to promote competitiveness among enterprises. ACC1Ó fosters the establishment and growth of new technology-based companies in Catalonia, enabling technology transfer from basic research and universities into the business world.

Dec 04, 2011

The scientists of Iproteos will attend the workshop organized by the European Federation for Medicinal Chemistry (EFMC) in Oegsteest (The Netherlands), which will be focused on the current safety and toxicity tests carried out in pre-clinical and clinical stages.

Sep 13, 2011

Iproteos will attend Europeptides 2011 in Berlin next November.

Sep 13, 2011

Iproteos participates at Bioemprenedor XXI competition. BioEmprenedorXXI is promoted by the main biotechnology agents of Spain “ la Caixa”, Barcelona Activa, Biocat, Genoma España and La Cambra de Comerç de Barcelona. The winner wil be announced in November.

Sep 05, 2011

Iproteos has been awarded with the Young Entrepreneur Prize from ASEBIO, Genoma España, SEBiot and SEBB. Dr. Teresa Tarragó, founder of Iproteos, received the young entrepreneur award in the Entrepreneur Forum held during the Conference of the Spanish Society of Biochemistry and Molecular Biology. The prize was sponsored by ASEBIO, Genoma España, SEBiot and SEBBM.

Jun 28, 2011

The Catalan biotech enterprise Iproteos, promoted by IRB Barcelona and the University of Barcelona, will apply new strategies to discover drugs with greater efficiency and fewer side effects. Iproteos, founded by Dr. Teresa Tarragó, researcher at Institute for Research in Biomedicine (IRB Barcelona) and Prof. Ernest Giralt, coordinator of the Chemistry and Molecular Pharmacology Programme at IRB Barcelona and senior professor of the University of Barcelona will search for peptides that block the activity of proteases, key therapeutic targets for the treatment of a wide range of diseases.